OPPENHEIMER ASSET MANAGEMENT INC. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$0
-100.0%
26
-99.8%
0.00%
-100.0%
Q4 2019$138,000
-4.2%
16,483
+3.9%
0.00%0.0%
Q3 2019$144,000
-4.6%
15,866
+13.0%
0.00%0.0%
Q2 2019$151,000
+21.8%
14,035
+7.7%
0.00%0.0%
Q1 2019$124,000
+21.6%
13,032
+47.3%
0.00%0.0%
Q4 2018$102,000
+8.5%
8,848
+41.0%
0.00%
+50.0%
Q3 2017$94,000
+38.2%
6,274
-19.0%
0.00%0.0%
Q2 2017$68,000
+78.9%
7,746
+5.7%
0.00%
+100.0%
Q1 2017$38,0007,3310.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders